Description
A selective HDAC1/3 inhibitor (IC50s = 199 and 69 nM for HDAC1 and HDAC3, respectively); selective for HDAC1 and HDAC3 (IC50 = >1.59 μM for HDAC2, 4, 5, 7, and 8 in a cell-free enzyme assay); improves the metabolic deficit exhibited by murine striatal cells isolated from HdhQ111 knock-in mice in a dose-dependent manner; reduces eye neurodegeneration in D. melanogaster model of Huntington’s disease; prevents formation of Htt aggregates in the brain and reduces the cognitive deficits in the N171-82Q mouse model of Huntington’s disease
Formal name: N1-(2-aminophenyl)-N7-phenyl-heptanediamide
Synonyms: Histone Deacetylase Inhibitor IV
Molecular weight: 325.4
CAS: 537034-15-4
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Deacetylases||Research Area|Epigenetics, Transcription, & Translation|Erasers|Histone Deacetylation||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Neurodegenerative Disorders